Characteristic | Physician diagnosis | Both criteria | Consensus criteria | p value* |
---|---|---|---|---|
N | 137 | 301 | 266 | Â |
Age (yr) | 1 (0.5–7) | 3 (0.7–10) | 3 (0.7–11) | 0.03 |
Sex, n (%) | Â | Â | Â | 0.74 |
 Male | 76 (55) | 164 (55) | 138 (52) |  |
 Female | 61 (45) | 137 (45) | 128 (48) |  |
Comorbid conditions, n (%) | Â | Â | Â | Â |
 Respiratory | 54 (39) | 73 (24) | 99 (37) | 0.001 |
 Gastrointestinal | 40 (29) | 62 (21) | 79 (30) | 0.03 |
 Cardiovascular | 34 (25) | 62 (21) | 74 (28) | 0.13 |
 Genetic | 35 (26) | 54 (18) | 61 (23) | 0.14 |
 Hematologic/immunologic | 28 (20) | 69 (23) | 45 (17) | 0.21 |
 Neuromuscular | 11 (8) | 37 (12) | 60 (23) | <0.001 |
 Neoplastic | 18 (13) | 51 (17) | 29 (11) | 0.11 |
 Prematurity | 37 (12) | 24 (18) | 39 (15) | 0.35 |
 Metabolic | 17 (12) | 28 (9) | 34 (13) | 0.38 |
 Renal | 15 (11) | 24 (8) | 31 (12) | 0.31 |
 Solid organ/stem cell transplant | 8 (6) | 28 (9) | 26 (10) | 0.39 |
Comorbid conditions, n (%) | Â | Â | Â | <0.001 |
 None | 30 (22) | 85 (28) | 43 (16) |  |
 1 | 21 (15) | 77 (26) | 64 (24) |  |
  ≥ 2 | 86 (63) | 21 (15) | 159 (60) |  |
Admission POPC, n (%) | Â | Â | Â | 0.13 |
 Good performance | 70 (51) | 170 (56) | 120 (45) |  |
 Mild disability | 26 (19) | 44 (15) | 41 (15) |  |
 Moderate disability | 22 (16) | 44 (15) | 46 (17) |  |
 Severe disability or coma | 19 (14) | 43 (14) | 59 (22) |  |
PIM-3 scorea | 3.6 (1.4–5.5) | 4.4 (1.9–9.2) | 4.3 (1.8–9.9) | <0.001 |
PELOD scoreb | 10 (1–11) | 11 (2–13) | 11 (2–12) | <0.001 |
Source of admission, n (%) | Â | Â | Â | 0.86 |
 Emergency departmentc | 41 (30) | 89 (30) | 78 (29) |  |
 Hospital floor | 39 (29) | 92 (31) | 66 (25) |  |
 Operating room | 12 (9) | 28 (9) | 22 (8) |  |
 Other hospitald | 39 (28) | 77 (26) | 89 (33) |  |
Organ dysfunction at sepsis recognitione | Â | Â | Â | Â |
 Cardiovascular | 51 (37) | 182 (61) | 106 (40) | <0.001 |
 Respiratory | 88 (64) | 211 (70) | 197 (74) | 0.12 |
 Renal | 5 (4) | 19 (6) | 7 (3) | 0.10 |
 Hepatic | 2 (1) | 16 (5) | 6 (2) | 0.07 |
 Hematologic | 4 (3) | 49 (16) | 24 (9) | <0.001 |
 Neurologic | 9 (7) | 28 (9) | 33 (12) | 0.17 |
Primary site of infection, n (%) | Â | Â | Â | Â |
 Respiratory | 60 (44) | 101 (34) | 127 (48) | 0.002 |
 Primary bloodstream | 25 (18) | 82 (27) | 26 (10) | <0.001 |
 Abdominal | 15 (11) | 31 (10) | 16 (6) | 0.11 |
 Central nervous system | 3 (2) | 9 (3) | 16 (6) | 0.11 |
 Genitourinary | 7 (5) | 12 (4) | 9 (3) | 0.67 |
 Skin | 4 (3) | 16 (5) | 4 (2) | 0.04 |
 Other | 6 (4) | 16 (5) | 13 (5) | 0.95 |
 Unknown | 17 (12) | 34 (11) | 55 (21) | 0.006 |
Microbiology,f,g n (%) | Â | Â | Â | Â |
 Gram-positive bacteria | 39 (28) | 90 (30) | 60 (23) | 0.13 |
 Gram-negative bacteria | 27 (20) | 95 (32) | 63 (24) | 0.02 |
 Fungus | 9 (7) | 39 (13) | 37 (14) | 0.07 |
 Virus | 35 (26) | 50 (17) | 69 (26) | 0.01 |
 No organism identified | 50 (36) | 95 (32) | 101 (38) | 0.25 |